Next Generation Genome Editing Market
完整報告名稱與涵蓋範圍
Next Generation Genome Editing Market Size, Share & Trends Analysis Distribution by Type of Gene Editing Technique (Recombinase-Based Editing, Prime Genome Editing, Bridge Editing, Base Editing, Retron Library Recombineering (RLR), Transposon-Based Systems, Homology-Directed Repair (HDR)), Application Area, Type of End User and Segment Forecasts, 2024-2031
報告摘要
The global Next Generation Genome Editing Market is set to witness notable expansion over the coming years.
At its core, Next Generation Genome Editing pertains to The Next Generation Genome Editing market is rapidly advancing with technologies that enhance the capabilities of CRISPR-Cas9, addressing its limitations and expanding its potential. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
Market momentum is fueled by escalating appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Next Generation Genome Editing Market Snapshot
Chapter 4. Global Next Generation Genome Editing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type of Gene Editing Technique Estimates & Trend Analysis
5.1. By Type of Gene Editing Technique & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Gene Editing Technique:
5.2.1. Recombinase-Based Editing
5.2.2. Prime Genome Editing
5.2.3. Bridge Editing
5.2.4. Base Editing
5.2.5. Retron Library Recombineering (RLR)
5.2.6. Transposon-Based Systems
5.2.7. Homology-Directed Repair (HDR)
5.2.8. Other emerging technologies
Chapter 6. Market Segmentation 2: By Application Area Estimates & Trend Analysis
6.1. By Application Area & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application Area:
6.2.1. Drug Discovery and Development
6.2.2. Diagnostics
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
7.2.1. Biotechnology Companies
7.2.2. Academic Institutions
7.2.3. Government Laboratories
7.2.4. Contract Research Organizations
Chapter 8. Next Generation Genome Editing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.1.2. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.1.3. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.1.4. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.2.2. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.2.3. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.2.4. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.3.2. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.3.3. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.3.4. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.4.2. Latin America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.4.3. Latin America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.4.4. Latin America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.5.2. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.5.3. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.5.4. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Addgene
9.2.2. Beam Therapeutics
9.2.3. Bio Palette Co., Ltd
9.2.4. Caribou Biosciences
9.2.5. Cellectis
9.2.6. Creative Biogene
9.2.7. CRISPR Therapeutics.
9.2.8. Danaher Corporation
9.2.9. EdiGene, Inc.
9.2.10. Editas Medicine
9.2.11. ElevateBio
9.2.12. GenKOre
9.2.13. GenScript
9.2.14. Horizon Discovery Ltd.
9.2.15. Inscripta, Inc
9.2.16. Integrated DNA Technologies (IDT)
9.2.17. Intellia Therapeutics
9.2.18. KromaTiD, Inc
9.2.19. Maravai LifeSciences
9.2.20. Merck KGaA
9.2.21. Pairwise
9.2.22. Precision BioSciences
9.2.23. ProQR Therapeutics
9.2.24. QI-Biodesign
9.2.25. Recombinetics
9.2.26. Revvity
9.2.27. Sangamo Therapeutics, Inc.
9.2.28. Scribe Therapeutics
9.2.29. Shape TX
9.2.30. Synthego
9.2.31. Synthorx (part of Sanofi)
9.2.32. Other prominent players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們